Please assess the completion status of the following clinical trial:

Trial Title: Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Males~* aged 50 years or older~* medical claim of EP~* prescription claim(s) for either a 5ARI or both 5ARI and AB (provided both are within 180 days of index date)~* continuously eligible for 3 months prior to and at least 5 months after their index prescription date.~Exclusion Criteria:~* Patients with prostate or bladder cancer~* any prostate-related surgical procedure within 5 months of index date~* prescription claim for finasteride indicative of male pattern baldness; AB monotherapy only; initiation of 5ARI occurring more than 180 days after initiation of AB

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early 5ARI Initiation (Type: None): Patients with EP receiving either 5ARI monotherapy or combination therapy (AB + 5ARI) with early initiation of 5ARI (within 30 days of initiation of AB)
- Late 5ARI Initiation (Type: None): Patients with EP receiving combination therapy (AB + 5ARI) with late initiation of 5ARI (within 31 to 180 days after initiation of AB)

Based on this trial design, predict the completion outcome and termination type (if applicable).